$42.88
-0.21-0.49%
At close: Jun 15, 5:00 PM EST
$43.55
0.671.56%
After Hours: 7:50 AM EST
Guardian Pharmacy Services Inc Stock Guidance
GRDNNYSE
Guardian Pharmacy Service (GRDN) last issued guidance on May 6, 2026 for fiscal year 2026. The company guided revenue in the range of $1.40B - $1.42B for the period.
Compared to prior guidance, Guardian Pharmacy Service maintained its revenue forecast from a prior range of $1.40B - $1.42B.
Guardian Pharmacy Service has issued 12 guidance updates between November 12, 2024 and May 6, 2026. During this period, the company raised its outlook 4 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 6, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$1.40B - $1.42B
Guardian Pharmacy Service Guidance History
Review all historical guidance issued by Guardian Pharmacy Service, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Guardian Pharmacy Service (GRDN)?
The most recent guidance for Guardian Pharmacy Service (GRDN) was reported on May 6, 2026 for the fiscal year 2026. Guardian Pharmacy Service forecasted revenue between $1.40B and $1.42B for the period.
What revenue range did Guardian Pharmacy Service (GRDN) guide for?
Guardian Pharmacy Service (GRDN) guided revenue in the range of $1.40B to $1.42B for the fiscal year 2026.
Did Guardian Pharmacy Service (GRDN) raise or lower guidance?
Guardian Pharmacy Service (GRDN) maintained its revenue guidance from a prior range of $1.40B - $1.42B to $1.40B - $1.42B for the fiscal year 2026.
When did Guardian Pharmacy Service (GRDN) last issue guidance?
Guardian Pharmacy Service (GRDN) last issued guidance on May 6, 2026 for the fiscal year 2026.
